What is Omnicell's D&A?

Omnicell (OMCL) reported D&A of $18.57M in Q1 2026.

How has Omnicell's D&A changed year-over-year?

Omnicell's D&A decreased by 7.1% year-over-year, from $20M to $18.57M.

What is the long-term trend for Omnicell's D&A?

Over 4 years (2021 to 2025), Omnicell's D&A has grown at a 1.9% compound annual growth rate (CAGR), from $72.99M to $78.81M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Omnicell OMCL D&A

D&A at other companies

Baxter InternationalBAX

$237M-4.0%

Becton, Dickinson and CompanyBDX

$563M-0.7%

BrightSpring Health Services, Inc.BTSG

$39.09M-7.3%

Guardian Pharmacy ServicesGRDN

$5.98M+13.5%

Cardinal HealthCAH

$248M+19.8%

ICU MedicalICUI

$50.03M+1.2%

Other financials

Income statement

See full

Revenue$309.9M+14.9%

Gross profit$140.4M+26.5%

Operating income$16.9M+245%

Net income$11.4M+262%

EPS (diluted)$0.25+267%

Balance sheet

See full

Cash & equivalents$291.0M-29.8%

Total debt$34.3M-23.1%

Total equity$1.3B0.0%

Total assets$2.0B-6.8%

Cash flow

See full

Operating cash flow$54.5M+110%

CapEx$12.4M+11.3%

Free cash flow$42.1M+185%

Valuation

See full

Market cap$1.75B-7.2%

Enterprise value$1.49B-0.4%

P/E113.2×—

P/S1.4×-0.2×

Profitability

See full

Gross margin43.5%+0.4pp

Operating margin2.7%+1.8pp

Net margin1.7%+1.1pp

FCF margin9.3%-1.7pp

Returns & leverage

See full

Return on equity1.6%+1.1pp

Debt / equity0×0.0×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Omnicell's D&A?: Omnicell (OMCL) reported D&A of $18.57M in Q1 2026.
How has Omnicell's D&A changed year-over-year?: Omnicell's D&A decreased by 7.1% year-over-year, from $20M to $18.57M.
What is the long-term trend for Omnicell's D&A?: Over 4 years (2021 to 2025), Omnicell's D&A has grown at a 1.9% compound annual growth rate (CAGR), from $72.99M to $78.81M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.